hotspot -WSS

hotspot

author：hotspot 2025-09-06 04:13:25 - browse：957

Surgeons look over an x-ray monitor showing an implanted pacemaker — coverage from STAT — Adobe

In her final presentation for health policy class at the University of Chicago, first-year medical student Robin Ji informed her classmates that the Food and Drug Administration does not require randomized controlled trials of most medical devices. Her peers’ immediate reaction was disbelief.

“One classmate kept asking me, are you sure?” Ji said. “I think he asked me twice. Then he went on his phone to check to see if it was actually true.”

Ji was sure. She had spent two years before going to medical school working as a policy analyst for Rita Redberg and Sanket Dhruva, medical safety experts at the University of California, San Francisco. In a recent national survey published by the UCSF team in Health Affairs, Ji learned that it’s not just her classmates who may have misconceptions about the FDA — only 17% of physicians surveyed felt they understood the FDA’s device approval process. Around 41% felt they understood the drug side.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： FDA seeks to regulate lab

focus

WSS

Did you have Obamacare on your GOP debate bingo card?

Nick Jonas talks about managing diabetes along with his career

What the Wegovy shortage looks like for doctors — and for patients

Would Medicare drug price negotiations stall in a shutdown?

Inequities make cancer less preventable for women: report

Biogen shutters digital health group, ends Apple study, in cost cutting move

entertainment

hotspot

entertainment

Heart attack and stroke risk calculators need revising

Massive project maps cells in human brain in unprecedented detail

Affirmative action in medical school literally saved lives

European regulators consider appeal over Amylyx ALS drug

Guidelines to prevent youth baseball injuries need more muscle

After a drawn out lobbying fight, ARPA

Hollywood unions extend contract negotiations for actors

Takeaways from AdvaMed, the largest medical devices conference

DIEP, the 'gold standard' of breast reconstruction, is under threat

Inequities make cancer less preventable for women: report

explore

European regulators consider appeal over Amylyx ALS drug

FDA seeks to regulate lab

European regulators recommend Amylyx's ALS drug be rejected

FDA seeks to regulate lab

STAT Readout: Today's biotech news includes Sana and Amylyx

Readout LOUD podcast: Merger Mondays, Ozempic panic

leisure time

Wikipedia

focus

entertainment